Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Accessibility

More about accessibility

Trouble using our website?
Contact us

Text logo ERN-EYE Tools
CPMS REDgistry Elearning Members area
Accessibility

Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) (NGF-OPG)

In this page

Clinical Trial

NCT05733572 Recruiting, Active
Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) (NGF-OPG)
Phase 2
Interventional

Disease

Disease type

Other

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

12/06/2023

Closing date

31/10/2025

Inclusion criteria :

More

Exclusion criteria :

More

Funding

public

Members involved

Main investigators

Pr Benedetto Falsini

Representative

Italy

See more

ERN EYE member investigating site

HCP : Principal investigators

More